-
BiO2 Medical’s Early Feasibility Pilot Study’s IDE Approval Sets Groundwork for the Pivotal ACCEPT Trial
BiO2 Medical, Inc., is among the first to receive U.S. Food and Drug Administration (FDA) approval of their Investigational Device Exemption (IDE) application to begin an Early Feasibility Pilot Study (EFPS) using the Angel™ Catheter. A multi-center Early Feasibility Pilot Study has been designed to ...
-
UK Hospital is the first in Europe to place BiO2 Medical’s combined triple lumen CVC/IVC Filter, known as the Angel™ Catheter, in a critically ill patient to protect from life-threatening Pulmonary Embolism
BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, is pleased to announce the first placement of their triple lumen Angel™ Catheter in the European Union. The ...
-
BiO2 Medical Raises $12M in Series C Funding
Published Friday, September 7, 2012 Read more: http://www.prnewswire.com/news-releases/bio2-medical-raises-12m-in-series-c-funding-168960556.html BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has recently secured $12M in Series C funding. The company worked closely with BiO2 Medical’s ...
-
Grants Awarded to 16 S.A. Biotech Companies
By Patrick Danner Published 04:27 p.m., Thursday, November 4, 2010 Read more: http://www.mysanantonio.com/business/local/article/Grants-awarded-to-16-S-A-biotech-companies-798883.php#ixzz1HLILEJZ2 Federal tax-credit grants totaling about $4.9 million have been awarded to 16 San Antonio biotechnology companies. The grants are among $1 billion that was made available under the health care reform legislation signed into law in March. Most ...
CAUTION - Investigational device.